{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:31:35Z","timestamp":1790155895773,"version":"4.0.1"},"reference-count":172,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Spanish Ministry of Economy, Industry and Competitiveness"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.virusres.2019.02.011","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T02:18:40Z","timestamp":1550542720000},"page":"22-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Drug repurposing for new, efficient, broad spectrum antivirals"],"prefix":"10.1016","volume":"264","author":[{"given":"Mois\u00e9s","family":"Garc\u00eda-Serradilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Risco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2019.02.011_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/v10020071","article-title":"Nonstructural proteins of alphavirus-potential targets for drug development","volume":"10","author":"Abu Bakar","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2019.02.011_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.293","article-title":"Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases","volume":"5","author":"Al-Bari","year":"2017","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.virusres.2019.02.011_bib0015","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00693-16","article-title":"Antagonism of the sodium-potassium ATPase impairs Chikungunya virus infection","volume":"7","author":"Ashbrook","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.virusres.2019.02.011_bib0020","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrd2012","article-title":"Sunitinib maleate","volume":"5","author":"Atkins","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.virusres.2019.02.011_bib0025","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1021\/bc900215b","article-title":"Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate","volume":"20","author":"Baram-Pinto","year":"2009","journal-title":"Bioconjug. Chem."},{"issue":"Suppl. 1","key":"10.1016\/j.virusres.2019.02.011_bib0030","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.burns.2014.09.009","article-title":"Silver in medicine: a brief history BC 335 to present","volume":"40","author":"Barillo","year":"2014","journal-title":"Burns"},{"key":"10.1016\/j.virusres.2019.02.011_bib0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/095632020601700505","article-title":"Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB\/c mice","volume":"17","author":"Barnard","year":"2006","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.virusres.2019.02.011_bib0040","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/nrmicro3132","article-title":"Past, present and future: 30 years of HIV research","volume":"11","author":"Barre-Sinoussi","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0045","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.chom.2016.07.004","article-title":"A screen of FDA-Approved drugs for inhibitors of zika virus infection","volume":"20","author":"Barrows","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virusres.2019.02.011_bib0050","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1172\/JCI89857","article-title":"Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects","volume":"127","author":"Bekerman","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.virusres.2019.02.011_bib0055","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1053\/j.gastro.2014.07.019","article-title":"Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication","volume":"147","author":"Berger","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virusres.2019.02.011_bib0060","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00725-18","article-title":"Development and validation of a phenotypic high-content imaging assay for assessing the antiviral activity of small-molecule inhibitors targeting zika virus","volume":"62","author":"Bernatchez","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2019.02.011_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000524","article-title":"Target cell cyclophilins facilitate human papillomavirus type 16 infection","volume":"5","author":"Bienkowska-Haba","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virusres.2019.02.011_bib0070","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000024948","article-title":"Examination of potential inhibitors of hepatitis A virus uncoating","volume":"41","author":"Bishop","year":"1998","journal-title":"Intervirology"},{"key":"10.1016\/j.virusres.2019.02.011_bib0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2014.03.014","article-title":"Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity","volume":"106","author":"Boonyasuppayakorn","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2019.02.011_bib0080","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.nano.2016.01.021","article-title":"Potential application of silver nanoparticles to control the infectivity of Rift Valley fever virus in vitro and in vivo","volume":"12","author":"Borrego","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.virusres.2019.02.011_bib0085","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1099\/vir.0.19074-0","article-title":"Requirement for cyclophilin A for the replication of vesicular stomatitis virus New Jersey serotype","volume":"84","author":"Bose","year":"2003","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0090","doi-asserted-by":"crossref","first-page":"170029","DOI":"10.1038\/sdata.2017.29","article-title":"A standard database for drug repositioning","volume":"4","author":"Brown","year":"2017","journal-title":"Sci. Data"},{"key":"10.1016\/j.virusres.2019.02.011_bib0095","doi-asserted-by":"crossref","DOI":"10.3390\/nano8090681","article-title":"Biomedical applications of silver nanoparticles: an up-to-Date overview","volume":"8","author":"Burdusel","year":"2018","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.virusres.2019.02.011_bib0100","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1128\/JVI.03274-14","article-title":"ATP1A1-mediated Src signaling inhibits coronavirus entry into host cells","volume":"89","author":"Burkard","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0105","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/1873-3468.12153","article-title":"Correlative light and electron microscopy methods for the study of virus-cell interactions","volume":"590","author":"Bykov","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1016\/j.virusres.2019.02.011_bib0110","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/AAC.01972-13","article-title":"In vitro combination of anti-cytomegalovirus compounds acting through different targets: role of the slope parameter and insights into mechanisms of Action","volume":"58","author":"Cai","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2019.02.011_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2014.11.010","article-title":"A screen of the NIH Clinical Collection small molecule library identifies potential anti-coronavirus drugs","volume":"114","author":"Cao","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2019.02.011_bib0120","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nchembio.2007.15","article-title":"Image-based chemical screening","volume":"3","author":"Carpenter","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0125","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/174930b0","article-title":"Effect of silver ions on mitochondrial adenosine triphosphatase","volume":"174","author":"Chappell","year":"1954","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2019.02.011_bib0130","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/77489","article-title":"Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo","volume":"6","author":"Chapuis","year":"2000","journal-title":"Nat. Med."},{"issue":"Pt 2","key":"10.1016\/j.virusres.2019.02.011_bib0135","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1099\/0022-1317-79-2-339","article-title":"Inhibition of vaccinia virus replication by cyclosporin A analogues correlates with their affinity for cellular cyclophilins","volume":"79","author":"Damaso","year":"1998","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0140","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1089\/vbz.2008.0049","article-title":"On chikungunya acute infection and chloroquine treatment","volume":"8","author":"De Lamballerie","year":"2008","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.virusres.2019.02.011_bib0145","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1099\/vir.0.034983-0","article-title":"Cyclosporin A inhibits the replication of diverse coronaviruses","volume":"92","author":"de Wilde","year":"2011","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0150","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1128\/AAC.03011-14","article-title":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture","volume":"58","author":"de Wilde","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2019.02.011_bib0155","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.virol.2018.06.011","article-title":"Cyclophilins and cyclophilin inhibitors in nidovirus replication","volume":"522","author":"de Wilde","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2019.02.011_bib0160","doi-asserted-by":"crossref","DOI":"10.3390\/v8120322","article-title":"Chloroquine, an endocytosis blocking agent, inhibits zika virus infection in different cell models","volume":"8","author":"Delvecchio","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2019.02.011_bib0165","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1743-422X-4-39","article-title":"Different pH requirements are associated with divergent inhibitory effects of chloroquine on human and avian influenza A viruses","volume":"4","author":"Di Trani","year":"2007","journal-title":"Virol. J."},{"key":"10.1016\/j.virusres.2019.02.011_bib0170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/viro.2002.1685","article-title":"Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA","volume":"304","author":"Diamond","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2019.02.011_bib0175","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: new estimates of R&D costs","volume":"47","author":"DiMasi","year":"2016","journal-title":"J. Health Econ."},{"key":"10.1016\/j.virusres.2019.02.011_bib0180","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.virol.2007.05.001","article-title":"Inhibitors of the sodium potassium ATPase that impair herpes simplex virus replication identified via a chemical screening approach","volume":"366","author":"Dodson","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2019.02.011_bib0185","doi-asserted-by":"crossref","DOI":"10.3390\/v8110277","article-title":"Antiviral screening of multiple compounds against ebola virus","volume":"8","author":"Dowall","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2019.02.011_bib0190","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1128\/AAC.03036-14","article-title":"Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection","volume":"58","author":"Dyall","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2019.02.011_bib0195","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1477-3155-3-6","article-title":"Interaction of silver nanoparticles with HIV-1","volume":"3","author":"Elechiguerra","year":"2005","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0200","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/1348-0421.12154","article-title":"Chloroquine interferes with dengue-2 virus replication in U937 cells","volume":"58","author":"Farias","year":"2014","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0205","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/vim.2014.0090","article-title":"Antiviral activity of chloroquine against dengue virus type 2 replication in Aotus monkeys","volume":"28","author":"Farias","year":"2015","journal-title":"Viral Immunol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/B978-0-12-801075-4.00003-3","article-title":"Metallothioneins for correlative light and electron microscopy","volume":"124","author":"Fernandez de Castro","year":"2014","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0215","first-page":"260","article-title":"Three-dimensional imaging of the intracellular assembly of a functional viral RNA replicase complex","volume":"130","author":"Fernandez de Castro","year":"2017","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.virusres.2019.02.011_bib0220","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2015.03.005","article-title":"Evaluation of Crimean-Congo hemorrhagic fever virus in vitro inhibition by chloroquine and chlorpromazine, two FDA approved molecules","volume":"118","author":"Ferraris","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2019.02.011_bib0225","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/hep.22131","article-title":"The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus","volume":"47","author":"Flisiak","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2019.02.011_bib0230","article-title":"Live-cell imaging of early steps of single HIV-1","volume":"10","author":"Francis","year":"2018","journal-title":"Infection. Viruses"},{"key":"10.1016\/j.virusres.2019.02.011_bib0235","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/372359a0","article-title":"Specific incorporation of cyclophilin A into HIV-1 virions","volume":"372","author":"Franke","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2019.02.011_bib0240","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1161\/CIRCULATIONAHA.105.560110","article-title":"Contemporary use of digoxin in the management of cardiovascular disorders","volume":"113","author":"Gheorghiade","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.virusres.2019.02.011_bib0245","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01623-16","article-title":"Suppression of adenovirus replication by cardiotonic steroids","volume":"91","author":"Grosso","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0250","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1742-4690-10-62","article-title":"Genistein interferes with SDF-1- and HIV-mediated actin dynamics and inhibits HIV infection of resting CD4 T cells","volume":"10","author":"Guo","year":"2013","journal-title":"Retrovirology"},{"key":"10.1016\/j.virusres.2019.02.011_bib0255","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7883\/yoken.66.276","article-title":"Cyclosporin A inhibits the propagation of influenza virus by interfering with a late event in the virus life cycle","volume":"66","author":"Hamamoto","year":"2013","journal-title":"Jpn. J. Infect. Dis."},{"key":"10.1016\/j.virusres.2019.02.011_bib0260","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1126\/science.6238408","article-title":"Cyclophilin: a specific cytosolic binding protein for cyclosporin A","volume":"226","author":"Handschumacher","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.virusres.2019.02.011_bib0265","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1007\/s00705-006-0824-x","article-title":"Ionic Contra-Viral Therapy (ICVT); a new approach to the treatment of DNA virus infections","volume":"151","author":"Hartley","year":"2006","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0270","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a015487","article-title":"Immunosuppressive drug therapy","volume":"3","author":"Hartono","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.virusres.2019.02.011_bib0275","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ymeth.2015.04.019","article-title":"Correlative light and electron microscopy enables viral replication studies at the ultrastructural level","volume":"90","author":"Hellstrom","year":"2015","journal-title":"Methods"},{"key":"10.1016\/j.virusres.2019.02.011_bib0280","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1053\/j.gastro.2006.08.027","article-title":"Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha","volume":"131","author":"Henry","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virusres.2019.02.011_bib0285","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-4939-7116-9_14","article-title":"Luciferase-expressing Ebolaviruses as tools for screening of antivirals","volume":"1628","author":"Hoenen","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0290","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1038\/emi.2012.47","article-title":"Emerging virus diseases: can we ever expect the unexpected?","volume":"1","author":"Howard","year":"2012","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.virusres.2019.02.011_bib0295","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.toxlet.2008.04.015","article-title":"The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells","volume":"179","author":"Hsin","year":"2008","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.virusres.2019.02.011_bib0300","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature09978","article-title":"Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORgammat activity","volume":"472","author":"Huh","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2019.02.011_bib0305","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12967-016-1031-5","article-title":"Repurposing of approved cardiovascular drugs","volume":"14","author":"Ishida","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.virusres.2019.02.011_bib0310","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.3390\/v6104095","article-title":"Current perspectives on HIV-1 antiretroviral drug resistance","volume":"6","author":"Iyidogan","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2019.02.011_bib0315","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/mt.2013.112","article-title":"Suppression of antiviral innate immunity by sunitinib enhances oncolytic virotherapy","volume":"21","author":"Jha","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virusres.2019.02.011_bib0320","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/nature06536","article-title":"Global trends in emerging infectious diseases","volume":"451","author":"Jones","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2019.02.011_bib0325","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1128\/AAC.00898-12","article-title":"Human cytomegalovirus inhibition by cardiac glycosides: evidence for involvement of the HERG gene","volume":"56","author":"Kapoor","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2019.02.011_bib0330","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/29dffb2a-5d37-4196-b166-b0b15bc2f3fd","article-title":"Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics","volume":"5","author":"Kaul","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virusres.2019.02.011_bib0335","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1089\/aid.2005.21.116","article-title":"Ex vivo modeling of the effects of mycophenolic acid on HIV infection: considerations for antiviral therapy","volume":"21","author":"Kaur","year":"2005","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virusres.2019.02.011_bib0340","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbrc.2004.08.085","article-title":"In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine","volume":"323","author":"Keyaerts","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virusres.2019.02.011_bib0345","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/jmv.21663","article-title":"Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against Chikungunya virus in vero cells","volume":"82","author":"Khan","year":"2010","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0350","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.nano.2006.12.001","article-title":"Antimicrobial effects of silver nanoparticles","volume":"3","author":"Kim","year":"2007","journal-title":"Nanomedicine"},{"key":"10.1016\/j.virusres.2019.02.011_bib0355","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF01875349","article-title":"Silver ion (Ag+)-induced increases in cell membrane K+ and Na+ permeability in the renal proximal tubule: reversal by thiol reagents","volume":"102","author":"Kone","year":"1988","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0360","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1021\/jm501759m","article-title":"Selective inhibitors of cyclin g associated kinase (GAK) as anti-hepatitis C agents","volume":"58","author":"Kovackova","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.virusres.2019.02.011_bib0365","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.antiviral.2018.05.002","article-title":"Minocycline suppresses dengue virus replication by down-regulation of macrophage migration inhibitory factor-induced autophagy","volume":"155","author":"Lai","year":"2018","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2019.02.011_bib0370","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/jac\/dkt471","article-title":"A novel cell-based high-throughput screen for inhibitors of HIV-1 gene expression and budding identifies the cardiac glycosides","volume":"69","author":"Laird","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.virusres.2019.02.011_bib0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-3155-8-1","article-title":"Mode of antiviral action of silver nanoparticles against HIV-1","volume":"8","author":"Lara","year":"2010","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.virusres.2019.02.011_bib0380","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1477-3155-8-15","article-title":"PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture","volume":"8","author":"Lara","year":"2010","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.virusres.2019.02.011_bib0385","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bbrc.2016.07.029","article-title":"Drug repurposing of minocycline against dengue virus infection","volume":"478","author":"Leela","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virusres.2019.02.011_bib0390","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0923-2516(90)90052-K","article-title":"Protective activity of tetracycline analogs against the cytopathic effect of the human immunodeficiency viruses in CEM cells","volume":"141","author":"Lemaitre","year":"1990","journal-title":"Res. Virol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0395","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.antiviral.2017.02.014","article-title":"Current therapy for chronic hepatitis C: the role of direct-acting antivirals","volume":"142","author":"Li","year":"2017","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2019.02.011_bib0400","doi-asserted-by":"crossref","first-page":"28978","DOI":"10.1038\/srep28978","article-title":"Cyclophilin A protects mice against infection by influenza A virus","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virusres.2019.02.011_bib0405","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ebiom.2017.09.034","article-title":"Chloroquine, a FDA-approved drug, prevents zika virus infection and its associated congenital microcephaly in mice","volume":"24","author":"Li","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.virusres.2019.02.011_bib0410","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.antiviral.2013.03.020","article-title":"Curing a viral infection by targeting the host: the example of cyclophilin inhibitors","volume":"99","author":"Lin","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2019.02.011_bib0415","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1462-5822.2009.01286.x","article-title":"Cyclophilin A interacts with influenza A virus M1 protein and impairs the early stage of the viral replication","volume":"11","author":"Liu","year":"2009","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0420","article-title":"Cyclosporin A inhibits the influenza virus replication through cyclophilin A-dependent and -independent pathways","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.virusres.2019.02.011_bib0425","article-title":"Cyclophilin A restricts influenza A virus replication through degradation of the M1 protein","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.virusres.2019.02.011_bib0430","first-page":"1","article-title":"Generation of functional organs from stem cells","volume":"2","author":"Liu","year":"2013","journal-title":"Cell Regen. (Lond.)"},{"key":"10.1016\/j.virusres.2019.02.011_bib0435","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-981-10-8727-1_21","article-title":"Countering zika virus: the USAMRIID response","volume":"1062","author":"Lowen","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0440","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/135965350801300210","article-title":"Silver nanoparticles inhibit hepatitis B virus replication","volume":"13","author":"Lu","year":"2008","journal-title":"Antivir. Ther. (Lond.)"},{"key":"10.1016\/j.virusres.2019.02.011_bib0445","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.bbrc.2004.07.003","article-title":"Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A","volume":"321","author":"Luo","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virusres.2019.02.011_bib0450","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.antiviral.2016.07.019","article-title":"Discovery of cyclosporine A and its analogs as broad-spectrum anti-influenza drugs with a high in vitro genetic barrier of drug resistance","volume":"133","author":"Ma","year":"2016","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2019.02.011_bib0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060579","article-title":"A systematic screen of FDA-approved drugs for inhibitors of biological threat agents","volume":"8","author":"Madrid","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.virusres.2019.02.011_bib0460","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/00126334-199908150-00002","article-title":"Abacavir and mycophenolic acid, an inhibitor of inosine monophosphate dehydrogenase, have profound and synergistic anti-HIV activity","volume":"21","author":"Margolis","year":"1999","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.virusres.2019.02.011_bib0465","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1128\/JVI.00592-14","article-title":"Imaging the alphavirus exit pathway","volume":"88","author":"Martinez","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0470","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1039\/C4NP00085D","article-title":"Antiviral drug discovery: broad-spectrum drugs from nature","volume":"32","author":"Martinez","year":"2015","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.virusres.2019.02.011_bib0475","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","article-title":"Mechanisms of action of cyclosporine","volume":"47","author":"Matsuda","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.virusres.2019.02.011_bib0480","first-page":"327","article-title":"In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic\/pharmacodynamic relationship","volume":"9","author":"Mendel","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.virusres.2019.02.011_bib0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2014.04.005","article-title":"Nucleoside\/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance","volume":"8","author":"Menendez-Arias","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0490","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.tim.2018.04.004","article-title":"Drug Repurposing for Viral Infectious Diseases: How Far Are We?","volume":"26","author":"Mercorelli","year":"2018","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0495","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jac\/dkm307","article-title":"Minocycline inhibits West Nile virus replication and apoptosis in human neuronal cells","volume":"60","author":"Michaelis","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.virusres.2019.02.011_bib0500","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/j.1471-4159.2008.05238.x","article-title":"Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis","volume":"105","author":"Mishra","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.virusres.2019.02.011_bib0505","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrd.2017.111","article-title":"Opportunities and challenges in phenotypic drug discovery: an industry perspective","volume":"16","author":"Moffat","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.virusres.2019.02.011_bib0510","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1088\/0957-4484\/16\/10\/059","article-title":"The bactericidal effect of silver nanoparticles","volume":"16","author":"Morones","year":"2005","journal-title":"Nanotechnology"},{"key":"10.1016\/j.virusres.2019.02.011_bib0515","doi-asserted-by":"crossref","first-page":"e3095","DOI":"10.1371\/journal.pntd.0003095","article-title":"High content image-based screening of a protease inhibitor library reveals compounds broadly active against Rift Valley fever virus and other highly pathogenic RNA viruses","volume":"8","author":"Mudhasani","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.virusres.2019.02.011_bib0520","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00436-015-4783-6","article-title":"Fighting arboviral diseases: low toxicity on mammalian cells, dengue growth inhibition (in vitro), and mosquitocidal activity of Centroceras clavulatum-synthesized silver nanoparticles","volume":"115","author":"Murugan","year":"2016","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.virusres.2019.02.011_bib0525","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbrc.2003.11.080","article-title":"Specific inhibition of hepatitis C virus replication by cyclosporin A","volume":"313","author":"Nakagawa","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virusres.2019.02.011_bib0530","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.lfs.2007.03.013","article-title":"The digitalis-like steroid hormones: new mechanisms of action and biological significance","volume":"80","author":"Nesher","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.virusres.2019.02.011_bib0535","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.1128\/JVI.02631-07","article-title":"Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3","volume":"82","author":"Neuman","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0540","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002845","article-title":"Identification and targeting of an interaction between a tyrosine motif within hepatitis C virus core protein and AP2M1 essential for viral assembly","volume":"8","author":"Neveu","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virusres.2019.02.011_bib0545","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1128\/JVI.02705-14","article-title":"AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets","volume":"89","author":"Neveu","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0550","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/534314a","article-title":"Can you teach old drugs new tricks?","volume":"534","author":"Nosengo","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2019.02.011_bib0555","doi-asserted-by":"crossref","first-page":"17047","DOI":"10.1038\/srep17047","article-title":"Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide","volume":"5","author":"Okuyama-Dobashi","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virusres.2019.02.011_bib0560","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1743-422X-3-39","article-title":"In vitro inhibition of human influenza A virus replication by chloroquine","volume":"3","author":"Ooi","year":"2006","journal-title":"Virol. J."},{"key":"10.1016\/j.virusres.2019.02.011_bib0565","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/hep.21102","article-title":"The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro","volume":"43","author":"Paeshuyse","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2019.02.011_bib0570","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/hep.25562","article-title":"Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo","volume":"55","author":"Pan","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2019.02.011_bib0575","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/1087057110374357","article-title":"Development of high-content imaging assays for lethal viral pathogens","volume":"15","author":"Panchal","year":"2010","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.virusres.2019.02.011_bib0580","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1002\/smll.201001349","article-title":"Inhibition of influenza virus infection by multivalent sialic-acid-functionalized gold nanoparticles","volume":"6","author":"Papp","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.virusres.2019.02.011_bib0585","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1473-3099(11)70065-2","article-title":"Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial","volume":"11","author":"Paton","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virusres.2019.02.011_bib0590","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.3390\/v7112902","article-title":"Resistance of hepatitis C virus to inhibitors: complexity and clinical implications","volume":"7","author":"Perales","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2019.02.011_bib0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002331","article-title":"The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors","volume":"7","author":"Pfefferle","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virusres.2019.02.011_bib0600","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4155\/fmc.11.92","article-title":"Target repurposing for neglected diseases","volume":"3","author":"Pollastri","year":"2011","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.virusres.2019.02.011_bib0605","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/nrd2682","article-title":"Novel therapeutic applications of cardiac glycosides","volume":"7","author":"Prassas","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.virusres.2019.02.011_bib0610","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.antiviral.2018.05.001","article-title":"Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment","volume":"155","author":"Pu","year":"2018","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2019.02.011_bib0615","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10787-015-0239-y","article-title":"Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases","volume":"23","author":"Rainsford","year":"2015","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.virusres.2019.02.011_bib0620","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0042-6822(90)90099-D","article-title":"Acidotropic amines inhibit proteolytic processing of flavivirus prM protein","volume":"174","author":"Randolph","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2019.02.011_bib0625","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev-virology-031413-085351","article-title":"Three-dimensional imaging of viral infections","volume":"1","author":"Risco","year":"2014","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0630","doi-asserted-by":"crossref","DOI":"10.3390\/v10050268","article-title":"Paradoxical effect of chloroquine treatment in enhancing Chikungunya virus infection","volume":"10","author":"Roques","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2019.02.011_bib0635","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00126334-200403010-00002","article-title":"Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors","volume":"35","author":"Savarino","year":"2004","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.virusres.2019.02.011_bib0640","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0008-8749(85)90046-2","article-title":"In vivo effects of cyclosporine on influenza A virus-infected mice","volume":"91","author":"Schiltknecht","year":"1985","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0645","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0960-9822(95)00197-7","article-title":"Protein folding. Prolyl isomerases join the fold","volume":"5","author":"Schmid","year":"1995","journal-title":"Curr. Biol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0650","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/dna.2017.4033","article-title":"Repurposing of kinase inhibitors as broad-spectrum antiviral drugs","volume":"37","author":"Schor","year":"2018","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0655","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1126\/science.1702904","article-title":"Chemistry and biology of the immunophilins and their immunosuppressive ligands","volume":"251","author":"Schreiber","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.virusres.2019.02.011_bib0660","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1128\/JVI.02027-14","article-title":"Unraveling the web of viroinformatics: computational tools and databases in virus research","volume":"89","author":"Sharma","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0665","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006841","article-title":"Origins of HIV and the AIDS pandemic","volume":"1","author":"Sharp","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.virusres.2019.02.011_bib0670","doi-asserted-by":"crossref","first-page":"15771","DOI":"10.1038\/s41598-017-15467-6","article-title":"Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis","volume":"7","author":"Shiryaev","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virusres.2019.02.011_bib0675","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0163-7258(93)90056-J","article-title":"Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum","volume":"57","author":"Slater","year":"1993","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.virusres.2019.02.011_bib0680","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1056\/NEJM198802113180606","article-title":"Digitalis. Mechanisms of action and clinical use","volume":"318","author":"Smith","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2019.02.011_bib0685","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1371\/journal.ppat.0030089","article-title":"Characterization of reemerging chikungunya virus","volume":"3","author":"Sourisseau","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virusres.2019.02.011_bib0690","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/aid.1993.9.91","article-title":"Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes","volume":"9","author":"Sperber","year":"1993","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virusres.2019.02.011_bib0695","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1477-3155-8-19","article-title":"Interaction of silver nanoparticles with Tacaribe virus","volume":"8","author":"Speshock","year":"2010","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.virusres.2019.02.011_bib0700","doi-asserted-by":"crossref","first-page":"8671","DOI":"10.1128\/JVI.01034-15","article-title":"Epidemiology, evolution, and recent outbreaks of avian influenza virus in China","volume":"89","author":"Su","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0705","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1007\/s00436-015-4556-2","article-title":"Green-synthesized silver nanoparticles as a novel control tool against dengue virus (DEN-2) and its primary vector Aedes aegypti","volume":"114","author":"Sujitha","year":"2015","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.virusres.2019.02.011_bib0710","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1021\/jm0204183","volume":"46","author":"Sun","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.virusres.2019.02.011_bib0715","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1039\/b510984a","article-title":"Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells","author":"Sun","year":"2005","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.virusres.2019.02.011_bib0720","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1086\/651277","article-title":"Minocycline attenuates HIV infection and reactivation by suppressing cellular activation in human CD4+ T cells","volume":"201","author":"Szeto","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2019.02.011_bib0725","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.stem.2015.03.004","article-title":"Vascularized and Complex Organ Buds from Diverse Tissues via Mesenchymal Cell-Driven Condensation","volume":"16","author":"Takebe","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.virusres.2019.02.011_bib0730","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1099\/vir.0.81655-0","article-title":"Inhibition of dengue virus replication by mycophenolic acid and ribavirin","volume":"87","author":"Takhampunya","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0735","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-4939-0348-1_7","article-title":"Cell-based flavivirus infection (CFI) assay for the evaluation of dengue antiviral candidates using high-content imaging","volume":"1138","author":"Tan","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0740","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1017\/S0950268815001570","article-title":"The pandemic potential of avian influenza A(H7N9) virus: a review","volume":"143","author":"Tanner","year":"2015","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.virusres.2019.02.011_bib0745","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01253-18","article-title":"Reovirus sigmaNS and muNS proteins remodel the endoplasmic reticulum to build replication neo-organelles","volume":"9","author":"Tenorio","year":"2018","journal-title":"MBio"},{"key":"10.1016\/j.virusres.2019.02.011_bib0750","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/372363a0","article-title":"Functional association of cyclophilin A with HIV-1 virions","volume":"372","author":"Thali","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2019.02.011_bib0755","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.imlet.2013.07.004","article-title":"Chloroquine: modes of action of an undervalued drug","volume":"153","author":"Thome","year":"2013","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.virusres.2019.02.011_bib0760","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.pharmthera.2013.06.008","article-title":"New perspectives in nanomedicine","volume":"140","author":"Thorley","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.virusres.2019.02.011_bib0765","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coviro.2015.04.010","article-title":"Host genes and influenza pathogenesis in humans: an emerging paradigm","volume":"14","author":"To","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0770","doi-asserted-by":"crossref","first-page":"e785","DOI":"10.1371\/journal.pntd.0000785","article-title":"A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults","volume":"4","author":"Tricou","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.virusres.2019.02.011_bib0775","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/aid.1990.6.481","article-title":"Inhibition of human immunodeficiency virus infectivity by chloroquine","volume":"6","author":"Tsai","year":"1990","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virusres.2019.02.011_bib0780","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2147\/IJN.S153167","article-title":"Nanosilver: new ageless and versatile biomedical therapeutic scaffold","volume":"13","author":"Ullah Khan","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.virusres.2019.02.011_bib0785","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pharmthera.2011.01.009","article-title":"Common cardiovascular medications in cancer therapeutics","volume":"130","author":"Vaklavas","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.virusres.2019.02.011_bib0790","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol. J."},{"key":"10.1016\/j.virusres.2019.02.011_bib0795","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1182\/blood.V72.6.1904.1904","article-title":"The effect of cyclosporine A on infection of susceptible cells by human immunodeficiency virus type 1","volume":"72","author":"Wainberg","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.virusres.2019.02.011_bib0800","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1465-9921-14-135","article-title":"Generation of a human airway epithelium derived basal cell line with multipotent differentiation capacity","volume":"14","author":"Walters","year":"2013","journal-title":"Respir. Res."},{"key":"10.1016\/j.virusres.2019.02.011_bib0805","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/hep.26982","article-title":"Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)","volume":"59","author":"Watashi","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2019.02.011_bib0810","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJM199609123351107","article-title":"The treatment of malaria","volume":"335","author":"White","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2019.02.011_bib0815","doi-asserted-by":"crossref","DOI":"10.3390\/v10040202","article-title":"Concepts in Light Microscopy of Viruses","volume":"10","author":"Witte","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2019.02.011_bib0820","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003241","article-title":"Digoxin suppresses HIV-1 replication by altering viral RNA processing","volume":"9","author":"Wong","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virusres.2019.02.011_bib0825","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jviromet.2011.09.003","article-title":"Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro","volume":"178","author":"Xiang","year":"2011","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virusres.2019.02.011_bib0830","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.2147\/IJN.S53622","article-title":"Inhibition of A\/Human\/Hubei\/3\/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo","volume":"8","author":"Xiang","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.virusres.2019.02.011_bib0835","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/cr.2012.165","article-title":"Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model","volume":"23","author":"Yan","year":"2013","journal-title":"Cell Res."},{"key":"10.1016\/j.virusres.2019.02.011_bib0840","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1128\/JVI.02614-07","article-title":"Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro","volume":"82","author":"Yang","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0845","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.antiviral.2017.07.007","article-title":"Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo","volume":"145","author":"Yuan","year":"2017","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2019.02.011_bib0850","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jhep.2012.09.022","article-title":"Host-targeting agents for prevention and treatment of chronic hepatitis C - perspectives and challenges","volume":"58","author":"Zeisel","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0855","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3389\/fmicb.2015.00517","article-title":"Broad-spectrum antiviral agents","volume":"6","author":"Zhu","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virusres.2019.02.011_bib0860","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.293.16.2003","article-title":"Neuroprotective and anti-human immunodeficiency virus activity of minocycline","volume":"293","author":"Zink","year":"2005","journal-title":"JAMA"}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170218307068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170218307068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:06:39Z","timestamp":1759154799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170218307068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":172,"alternative-id":["S0168170218307068"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2019.02.011","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug repurposing for new, efficient, broad spectrum antivirals","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2019.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}